Septerna (SEPN) Total Liabilities (2023 - 2026)
Septerna (SEPN) recorded quarterly Total Liabilities of $191.2 million in Q1 2026, down 10.75% quarter-over-quarter from $214.3 million in Q4 2025, and up 466.54% on a YoY basis from $33.8 million in Q1 2025.
Septerna (SEPN) Total Liabilities (2023 - 2026) Analysis & Trends
Septerna's Total Liabilities history runs 4 years deep, the most recent figure standing at $191.2 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 466.54% year-over-year to $191.2 million; the TTM figure through Mar 2026 stood at $191.2 million (up 466.54% YoY), while the FY2025 annual figure was $214.3 million, up 486.9% from the prior year.
- Total Liabilities was $191.2 million for Q1 2026 at Septerna, down from $214.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $217.9 million in Q3 2025 to a low of $20.0 million in Q4 2023.
- Historically, Total Liabilities has averaged $89.3 million across 4 years, with a median of $51.9 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities tumbled 49.18% in 2024, then surged 486.9% in 2025.
- A 4-year view of Total Liabilities shows it stood at $20.0 million in 2023, then surged by 82.3% to $36.5 million in 2024, then soared by 486.9% to $214.3 million in 2025, then dropped by 10.75% to $191.2 million in 2026.
- The last three Total Liabilities figures came in at $191.2 million (Q1 2026), $214.3 million (Q4 2025), and $217.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 191.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 191.23 Mn |
| Dec 31, 2025 | 214.26 Mn |
| Sep 30, 2025 | 217.92 Mn |
| Jun 30, 2025 | 37.67 Mn |
| Mar 31, 2025 | 33.75 Mn |
| Dec 31, 2024 | 36.51 Mn |
| Sep 30, 2024 | 37.53 Mn |
| Jun 30, 2024 | 67.76 Mn |
| Mar 31, 2024 | 51.89 Mn |
| Dec 31, 2023 | 20.03 Mn |
| Sep 30, 2023 | 73.85 Mn |